Kilspax

Phloroglucinol, the active ingredient in Kilspax, is an antispasmodic presented as an oral dosage form for oral use. It helps relieve smooth‑muscle spasms that cause abdominal pain, biliary colic, renal colic and menstrual cramps in adult patients, and is indicated for use in both acute and recurrent episodes.

GNH USA supplies Kilspax as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing reliable sourcing, regulatory support and global logistics for consistent product availability and ensures compliance with EU pharmacopeial standards.

Kilspax (phloroglucinol) acts as a smooth‑muscle relaxant to alleviate spasm‑related conditions.

Abdominal pain: reduces painful intestinal spasms, improving comfort. Biliary colic: relaxes biliary smooth muscle, facilitating bile flow and relieving colicky pain. Renal colic: eases ureteral smooth‑muscle spasm, helping to diminish flank pain. Menstrual cramps: diminishes uterine muscle contractions, decreasing dysmenorrhea severity.

Phloroglucinol may be associated with several adverse reactions, most of which are mild and reversible.

Common Side Effects: - Nausea - Dizziness - Headache - Dry mouth - Abdominal discomfort - Diarrhoea

Serious or Rare Side Effects: - Allergic reactions (rash, urticaria) - Severe hypotension - Hepatic enzyme elevation - Anaphylaxis - Severe neutropenia

Before prescribing Kilspax, clinicians should consider the following precautions.

Assess renal function: adjust use in severe renal impairment. Avoid in known hypersensitivity to phloroglucinol. Use caution in patients with hepatic disease. Monitor for signs of allergic reaction during initial therapy. Store below 25°C: keep in the original pack, protect from moisture.

Potential drug interactions should be reviewed prior to initiating therapy.

Major Interactions (Avoid): - Concurrent use with other antispasmodics: additive muscle relaxation may cause severe hypotension. - Combination with potent CYP inhibitors: may increase plasma levels of phloroglucinol.

Moderate Interactions (Monitor Closely): - Co‑administration with antihypertensives: may enhance blood‑pressure‑lowering effect. - Use with diuretics: monitor electrolyte balance. - Concurrent use with drugs that prolong QT interval: monitor cardiac rhythm.